4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-001105
CHIEF EXECUTIVE OFFICER gave up 577 shares (to pay taxes)
- CHIEF EXECUTIVE OFFICER acquired 1,875 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Williams Gregory C. · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-04-30 | Exercise or conversion : show line 1 in the form | +1,875 | 6,785 | D | ||
| 2020-04-30 | Shares withheld for taxes : show line 2 in the form | −577 | $2.92 | $1,685 | 6,208 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-04-30 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −1,875 | 20,625 | D |
Loading xslF345X03/form4-05012020_050506.xml…